ACARBOSE,ACETYCSTINE,PARACETAMOL,ALPRAZOLAM,HAND,TAB,AMLODIPINE,ANGISPANTR,ARIPIPRAZOLE,ATORVASTATI
Hqids
SOUTH ANDAMAN, ANDAMAN & NICOBAR
Bid Publish Date
22-Apr-2025, 11:26 am
Bid End Date
02-Jun-2025, 3:00 pm
Location
Progress
RAQuantity
40427184
Bid Type
Two Packet Bid
A tender has been published for N/a Antacid Tab, Acetazolamide, Acetyl Salicylic Acid Tab, Albendazole, Alprazolam, Amitriptyline HCL, Amlodipine, Amoxycillin Trihydrate, Ascorbic Acid, Atenolol, Atorvastatin, Azithromycin, B Complex Vitamin, Bisacodyl tablet, Bromhexine, Betahistine Hcl, Calcium citrate carbonate, Carbamazepine, Carvedelol, Cetrizine, Charcoal, Chloroquine Phosphate, Ciprofloxacin Hydrochloride, Clonidine Hydrochloride, Clopidogrel, Cefixime, Domperidon, Dexamethasone, Diclofenac Sodium, Digoxin, Diltiazem Hydrochloride, Dothiepin Hydrochloride, Doxycycline Hydrochloride, Drotaverine, Enalapril Maleate, Erythromycin Stearate, Ferrous Salt, Fluconazole, Fluoxetine HCL Capsule, Folic acid, Glibenclamide, Glimepiride, Haloperidol, Hydroxychloroquine, Hyoscine Butyl Bromide, Imipramine HCL, Isosorbide Dinitrate, Isosorbide Mononitrate, Itraconazole, Lorazepam, Lithium carbonate, Levetiracetam, Metformin, Metronidazole, Metoclopramide Hcl, Metoprolol, Multivitamins, Norfloxacin, Olanzepine, Pantoprazole, Paracetamol, Pheniramine Maleate, Phenobarbitone, Phenytoin Sodium, Prednisolone, Pregabalin, Rosuvastatin, Propranolol Hcl, Ranitidine Hcl, Resperidone, Salbutamol, Sodium Valproate, Spironolactone, Sertaline, Theophyllin, Thyroxin Sodium, Trifluoperazine Hcl, Trihexiphenidyl, Trimethoprim, Torsamide, Thiamine in CENTRAL DELHI, DELHI. Quantity: 40427184 by. Submission Deadline: 02-06-2025 15: 00: 00. Check eligibility and apply.
Main Document
BOQ
BOQ
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Hqids
SOUTH ANDAMAN, ANDAMAN & NICOBAR
Indian Air Force
BELGAUM, KARNATAKA
Border Security Force (bsf)
COOCH BEHAR, WEST BENGAL
Dg Of Defence Estate
PATNA, BIHAR
N/a
NAGPUR, MAHARASHTRA
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Antacid Tab | as per specifications | 51,000 | nos | manoj12 | 365 |
| 2 | Acetazolamide | as per specifications | 40,020 | nos | manoj12 | 365 |
| 3 | Acetyl Salicylic Acid Tab | as per specifications | 2,600,100 | nos | manoj12 | 365 |
| 4 | Albendazole | as per specifications | 15,000 | nos | manoj12 | 365 |
| 5 | Alprazolam | as per specifications | 150,000 | nos | manoj12 | 365 |
| 6 | Amitriptyline HCL | as per specifications | 320,100 | nos | manoj12 | 365 |
| 7 | Amlodipine | as per specifications | 1,500,000 | nos | manoj12 | 365 |
| 8 | Amoxycillin Trihydrate | as per specifications | 20,100 | nos | manoj12 | 365 |
| 9 | Amoxycillin Trihydrate | as per specifications | 450,000 | nos | manoj12 | 365 |
| 10 | Ascorbic Acid | as per specifications | 350,100 | nos | manoj12 | 365 |
| 11 | Atenolol | as per specifications | 30,000 | nos | manoj12 | 365 |
| 12 | Atorvastatin | as per specifications | 1,500,000 | nos | manoj12 | 365 |
| 13 | Atorvastatin | as per specifications | 1,000,020 | nos | manoj12 | 365 |
| 14 | Azithromycin | as per specifications | 100,020 | nos | manoj12 | 365 |
| 15 | B Complex Vitamin | as per specifications | 1,200,000 | nos | manoj12 | 365 |
| 16 | Bisacodyl tablet | as per specifications | 20,100 | nos | manoj12 | 365 |
| 17 | Bromhexine | as per specifications | 2,010 | nos | manoj12 | 365 |
| 18 | Betahistine Hcl | as per specifications | 120,000 | nos | manoj12 | 365 |
| 19 | Calcium citrate carbonate | as per specifications | 3,000,000 | nos | manoj12 | 365 |
| 20 | Carbamazepine | as per specifications | 400,020 | nos | manoj12 | 365 |
| 21 | Carvedelol | as per specifications | 200,100 | nos | manoj12 | 365 |
| 22 | Cetrizine | as per specifications | 600,000 | nos | manoj12 | 365 |
| 23 | Charcoal | as per specifications | 40,020 | nos | manoj12 | 365 |
| 24 | Chloroquine Phosphate | as per specifications | 1,020 | nos | manoj12 | 365 |
| 25 | Ciprofloxacin Hydrochloride | as per specifications | 80,100 | nos | manoj12 | 365 |
| 26 | Clonidine Hydrochloride | as per specifications | 500,100 | nos | manoj12 | 365 |
| 27 | Clopidogrel | as per specifications | 600,000 | nos | manoj12 | 365 |
| 28 | Cefixime | as per specifications | 100,020 | nos | manoj12 | 365 |
| 29 | Domperidon | as per specifications | 120,000 | nos | manoj12 | 365 |
| 30 | Dexamethasone | as per specifications | 50,010 | nos | manoj12 | 365 |
| 31 | Diclofenac Sodium | as per specifications | 1,000,020 | nos | manoj12 | 365 |
| 32 | Digoxin | as per specifications | 25,020 | nos | manoj12 | 365 |
| 33 | Diltiazem Hydrochloride | as per specifications | 100,020 | nos | manoj12 | 365 |
| 34 | Dothiepin Hydrochloride | as per specifications | 100,020 | nos | manoj12 | 365 |
| 35 | Doxycycline Hydrochloride | as per specifications | 100,020 | nos | manoj12 | 365 |
| 36 | Drotaverine | as per specifications | 35,040 | nos | manoj12 | 365 |
| 37 | Enalapril Maleate | as per specifications | 800,040 | nos | manoj12 | 365 |
| 38 | Erythromycin Stearate | as per specifications | 2,010 | nos | manoj12 | 365 |
| 39 | Ferrous Salt | as per specifications | 800,040 | nos | manoj12 | 365 |
| 40 | Fluconazole | as per specifications | 20,010 | nos | manoj12 | 365 |
| 41 | Fluoxetine HCL Capsule | as per specifications | 350,010 | nos | manoj12 | 365 |
| 42 | Folic acid | as per specifications | 800,010 | nos | manoj12 | 365 |
| 43 | Glibenclamide | as per specifications | 510 | nos | manoj12 | 365 |
| 44 | Glimepiride | as per specifications | 400,020 | nos | manoj12 | 365 |
| 45 | Glimepiride | as per specifications | 500,010 | nos | manoj12 | 365 |
| 46 | Haloperidol | as per specifications | 150,000 | nos | manoj12 | 365 |
| 47 | Hydroxychloroquine | as per specifications | 200,010 | nos | manoj12 | 365 |
| 48 | Hyoscine Butyl Bromide | as per specifications | 120,000 | nos | manoj12 | 365 |
| 49 | Imipramine HCL | as per specifications | 30,000 | nos | manoj12 | 365 |
| 50 | Isosorbide Dinitrate | as per specifications | 200,010 | nos | manoj12 | 365 |
| 51 | Isosorbide Mononitrate | as per specifications | 500,010 | nos | manoj12 | 365 |
| 52 | Itraconazole | as per specifications | 150,000 | nos | manoj12 | 365 |
| 53 | Lorazepam | as per specifications | 600,000 | nos | manoj12 | 365 |
| 54 | Lithium carbonate | as per specifications | 100,020 | nos | manoj12 | 365 |
| 55 | Levetiracetam | as per specifications | 700,020 | nos | manoj12 | 365 |
| 56 | Metformin | as per specifications | 2,000,010 | nos | manoj12 | 365 |
| 57 | Metronidazole | as per specifications | 50,010 | nos | manoj12 | 365 |
| 58 | Metoclopramide Hcl | as per specifications | 20,010 | nos | manoj12 | 365 |
| 59 | Metoprolol | as per specifications | 1,300,020 | nos | manoj12 | 365 |
| 60 | Multivitamins | as per specifications | 1,000,020 | nos | manoj12 | 365 |
| 61 | Norfloxacin | as per specifications | 20,010 | nos | manoj12 | 365 |
| 62 | Olanzepine | as per specifications | 700,020 | nos | manoj12 | 365 |
| 63 | Pantoprazole | as per specifications | 3,500,010 | nos | manoj12 | 365 |
| 64 | Paracetamol | as per specifications | 1,100,010 | nos | manoj12 | 365 |
| 65 | Pheniramine Maleate | as per specifications | 10,020 | nos | manoj12 | 365 |
| 66 | Phenobarbitone | as per specifications | 30,000 | nos | manoj12 | 365 |
| 67 | Phenytoin Sodium | as per specifications | 300,000 | nos | manoj12 | 365 |
| 68 | Prednisolone | as per specifications | 100,020 | nos | manoj12 | 365 |
| 69 | Pregabalin | as per specifications | 170,010 | nos | manoj12 | 365 |
| 70 | Rosuvastatin | as per specifications | 300,000 | nos | manoj12 | 365 |
| 71 | Prednisolone | as per specifications | 160,020 | nos | manoj12 | 365 |
| 72 | Propranolol Hcl | as per specifications | 300,000 | nos | manoj12 | 365 |
| 73 | Ranitidine Hcl | as per specifications | 1,000,020 | nos | manoj12 | 365 |
| 74 | Resperidone | as per specifications | 180,000 | nos | manoj12 | 365 |
| 75 | Salbutamol | as per specifications | 2,010 | nos | manoj12 | 365 |
| 76 | Sodium Valproate | as per specifications | 2,100,000 | nos | manoj12 | 365 |
| 77 | Spironolactone | as per specifications | 100,020 | nos | manoj12 | 365 |
| 78 | Spironolactone | as per specifications | 100,020 | nos | manoj12 | 365 |
| 79 | Sertaline | as per specifications | 500,010 | nos | manoj12 | 365 |
| 80 | Sertaline | as per specifications | 100,020 | nos | manoj12 | 365 |
| 81 | Theophyllin | as per specifications | 10,020 | nos | manoj12 | 365 |
| 82 | Theophyllin | as per specifications | 90,000 | nos | manoj12 | 365 |
| 83 | Thyroxin Sodium | as per specifications | 400,020 | nos | manoj12 | 365 |
| 84 | Thyroxin Sodium | as per specifications | 600,000 | nos | manoj12 | 365 |
| 85 | Trifluoperazine Hcl | as per specifications | 22,020 | nos | manoj12 | 365 |
| 86 | Trihexiphenidyl | as per specifications | 600,000 | nos | manoj12 | 365 |
| 87 | Trimethoprim | as per specifications | 70,002 | nos | manoj12 | 365 |
| 88 | Torsamide | as per specifications | 400,002 | nos | manoj12 | 365 |
| 89 | Thiamine | as per specifications | 150,000 | nos | manoj12 | 365 |
Discover companies most likely to bid on this tender
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Extended Deadline
02-Jun-2025, 3:00 pm
Opening Date
02-Jun-2025, 3:30 pm
Extended Deadline
29-May-2025, 3:00 pm
Opening Date
29-May-2025, 3:30 pm
Start
31-Oct-2025, 8:00 pm
End
03-Nov-2025, 10:00 am
Duration: 62 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 29-05-2025 12:27:21 | Evaluated |
| 2 | ********** Under PMA | - | 22-05-2025 11:46:12 | Evaluated |
| 3 | ********** Under PMA | - | 17-05-2025 17:58:34 | Evaluated |
| 4 | ********** Under PMA | - | 21-05-2025 17:08:17 | Evaluated |
| 5 | ********** Under PMA | - | 19-05-2025 10:14:52 | Evaluated |
| 6 | ********** Under PMA | - | 21-05-2025 17:27:55 | Evaluated |
| 7 | ********** Under PMA | - | 21-05-2025 16:12:59 | Evaluated |
| 8 | ********** Under PMA | - | 21-05-2025 15:44:18 | Evaluated |
| 9 | ********** Under PMA | - | 10-05-2025 16:08:43 | Evaluated |
| 10 | ********** Under PMA | - | 21-05-2025 17:39:00 | Evaluated |
| 11 | ********** Under PMA | - | 29-05-2025 14:56:38 | Evaluated |
| 12 | ********** Under PMA | - | 28-05-2025 12:38:16 | Evaluated |
| 13 | ********** Under PMA | - | 20-05-2025 18:02:54 | Evaluated |
| 14 | ********** Under PMA | - | 22-05-2025 10:23:35 | Evaluated |
| 15 | ********** Under PMA | - | 21-05-2025 15:39:17 | Evaluated |
| 16 | ********** Under PMA | - | 02-05-2025 11:10:20 | Evaluated |
| 17 | ********** Under PMA | - | 22-05-2025 11:56:22 | Evaluated |
| 18 | ********** Under PMA | - | 21-05-2025 19:31:20 | Evaluated |
| 19 | ********** Under PMA | - | 21-05-2025 17:13:44 | Evaluated |
| 20 | ********** Under PMA | - | 28-05-2025 17:03:47 | Evaluated |
| 21 | ********** Under PMA | - | 22-05-2025 11:14:07 | Evaluated |
| 22 | ********** Under PMA | - | 17-05-2025 09:36:06 | Evaluated |
| 23 | ********** Under PMA | - | 28-05-2025 17:34:54 | Evaluated |
| 24 | ********** Under PMA | - | 21-05-2025 23:34:07 | Evaluated |
| 25 | ********** Under PMA | - | 01-06-2025 18:13:41 | Evaluated |
| 26 | ********** Under PMA | - | 21-05-2025 18:38:02 | Evaluated |
| 27 | ********** Under PMA | - | 02-06-2025 13:18:44 | Evaluated |
| 28 | ********** Under PMA | - | 06-05-2025 08:42:44 | Evaluated |
| 29 | ********** Under PMA | - | 21-05-2025 19:13:51 | Evaluated |
| 30 | ********** Under PMA | - | 28-05-2025 14:53:59 | Evaluated |
| 31 | ********** Under PMA | - | 29-05-2025 12:13:49 | Evaluated |
| 32 | ********** Under PMA | - | 29-05-2025 13:23:58 | Evaluated |
| 33 | ********** Under PMA | - | 20-05-2025 16:51:58 | Evaluated |
| 34 | ********** Under PMA | - | 21-05-2025 17:38:14 | Evaluated |
| 35 | ********** Under PMA | - | 31-05-2025 18:55:58 | Evaluated |
| 36 | ********** Under PMA | - | 20-05-2025 12:12:21 | Evaluated |
| 37 | ********** Under PMA | - | 20-05-2025 19:29:11 | Evaluated |
| 38 | ********** Under PMA | - | 26-04-2025 15:23:12 | Evaluated |
| 39 | ********** Under PMA | - | 22-05-2025 11:08:09 | Evaluated |
| 40 | ********** Under PMA | - | 29-05-2025 14:38:32 | Evaluated |
| 41 | ********** Under PMA | - | 28-05-2025 18:26:22 | Evaluated |
| 42 | ********** Under PMA | - | 22-05-2025 11:53:38 | Evaluated |
| 43 | ********** Under PMA | - | 21-05-2025 15:33:59 | Evaluated |
| 44 | ********** Under PMA | - | 20-05-2025 12:13:51 | Evaluated |
| 45 | ********** Under PMA | - | 22-05-2025 11:52:50 | Evaluated |
| 46 | ********** Under PMA | - | 27-05-2025 13:42:21 | Evaluated |
| 47 | ********** Under PMA | - | 22-05-2025 11:11:29 | Evaluated |
| 48 | ********** Under PMA | - | 14-05-2025 16:07:25 | Evaluated |
| 49 | ********** Under PMA | - | 22-05-2025 11:26:00 | Evaluated |
| 50 | ********** Under PMA | - | 29-05-2025 13:13:21 | Evaluated |
| 51 | ********** Under PMA | - | 21-05-2025 17:28:11 | Evaluated |
Key insights about DELHI tender market
The eligibility requirements for participation include being a registered entity with a demonstrated track record in supplying pharmaceuticals. Prospective bidders must comply with local sourcing regulations and be able to provide documentation that evidences prior experience in similar projects.
Bidders must adhere to stringent technical specifications, ensuring that all medicines comply with quality standards as set by relevant health authorities. Documentation confirming the efficacy, safety, and reliability of the medications must be submitted alongside the proposal.
Yes, bidders will need to submit an Earnest Money Deposit (EMD) as part of their financial proposal. Details regarding the specific amount and submission method will be outlined in the tender documentation, ensuring bidders demonstrate their financial commitment.
Submissions must be made electronically or physically according to instructions provided within the tender documentation. Bidders should closely adhere to all key timelines to ensure their proposals are considered for evaluation and selection. Notifications about the results will follow the evaluation process.
Special provisions exist to support Micro, Small, and Medium Enterprises (MSEs) and startups. They may receive preference during the evaluation process, including benefits that encourage local sourcing in line with 'Make in India' initiatives and local content rules, supporting their growth within the sourcing framework.
Sign up now to access all documents
Main Document
BOQ
BOQ
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS